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Objectives. Thoracic endovascular aortic repair is associated with postoperative spinal cord ischemia in approximately
1 to 12.5% of all cases.
S100b is a protein that is released during acute damage of the central nervous system. This study was performed to
determine the concentration of S100b in cerebrospinal fluid during and after stenting of the thoracic aorta in patients
at high risk for spinal cord ischemia.
Design. Prospective clinical study.
Materials and methods. Eight patients who underwent elective thoracic aortic stent grafting underwent lumbar spinal
fluid drainage. These patients were at high risk to develop spinal cord ischemia.
Methods. CSF samples for analysis of S100b protein were drawn after induction of anesthesia, during stenting, once every
hour the following six hours and 20 hours after repair.
Results. No significant increase in S100b protein could be detected in CSF and no neurological deficits were detected
postoperatively.
Conclusions. The results of this study show us that there is no significant release of S100b protein in CSF during stenting
of the thoracic aorta in this subgroup of patients at high risk for spinal cord ischemia, consistent with clinical exam that
there was no significant damage to the central nervous system.
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Surgical treatment of thoracic and thoracoabdominal
aortic aneurysms may be associated with a significant
risk of perioperative morbidity, including paraplegia
and paraparesis. The risk to develop paraplegia or par-
aparesis has been reported to be 4 to 21%.1 In selected
thoracic aneurysms, there is a possibility for endo-
vascular aortic repair, which is accompanied with far
less morbidity and mortality. The risk to develop post-
operative paraplegia or paraparesis however remains
1 to 12.5%with an average of 2.7%.2,3 Probable risk fac-
tors for paraplegia include previous abdominal aortic
aneurysm repair,4 longer length of the thoracic aorta
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the endograft5 and postoperative hypotension.6
Cerebrospinal fluid (CSF) drainage theoretically
can improve the blood supply to the spinal cord.
CSF drainage reduces the risk of postoperative para-
plegia after open surgical repair of thoracic and thor-
acoabdominal aneurysms.1,7,8
The use of biochemical markers may be a sensitive
detection method to detect spinal cord ischemia.9,10
The S100b protein is such amarker: it is a calcium bind-
ing protein which is found in high concentrations in
glial and Schwann cells and is unique to the central ner-
vous system. The S100bprotein is releasedduring acute
damage of the central nervous system such as spinal
cord ischemia due to hypoperfusion.11 A rise in S100b
protein concentration in CSF correlates with a decrease
in the amplitude of transcranial motor evoked poten-
tials12 and may be a sensitive marker for detection of
damage to the central nervous system.9 S100b protein
concentrations in CSF are probably more sensitive in
detecting damage to the central nervous system thanrved.
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tein in CSF range from approximately 0.9 to 1.7 mg/L
andmay rise to approximately 4.0 mg/L during surgical
thoracoabdominal aortic replacement without post-
operative neurological deficits.11
This study was performed to determine the concen-
tration of S100b protein in CSF during and after stent-
ing of the thoracic aorta in patients at high risk for
spinal cord ischemia.
Materials and Methods
Eight patients, three men and five women, aged 58 to
76 years (mean, 68 years) who underwent elective tho-
racic aortic stent grafting participated in the study.
All patients were free from any neuromuscular dis-
order. The spinal fluid drainage and S100b measure-
ments were approved by the Institutional Ethics
Committee.
All stent grafts were inserted for treatment of tho-
racic aortic aneurysms. The studied patients were
considered at a higher risk than the previously men-
tioned 2.7% to develop postoperative paraplegia or
paraparesis. This assumption was made because
the aneurysms involved critical intercostal arteries
(T8-L2), the total thoracic descending aorta was to
be covered or the patient had a history of previous
abdominal aortic aneurysm repair. For these reasons
patients underwent lumbar spinal fluid drainage in
order to keep the spinal fluid pressure at a maximal
level of 10 mm Hg. The catheter (Integra Neuro-
Sciences Implants S.A., Sophia Antipolis, France) was
left in place for 20 hours postoperatively.
In one patient critical intercostal arteries (T8-L2)
were covered, after previous surgical treatment of an
abdominal aortic aneurysm. The other seven patients
received stents covering the total thoracic descending
aorta. Four of these seven patients also had a history
of abdominal aneurysm repair.
CSF samples for analysis of S100b protein were
drawn after induction of anesthesia, during stenting,
once every hour the following six hours and 20 hours
after repair.
One patient was considered to run a higher risk of
developing postoperative paraplegia or paraparesis
compared to the other patients. This assessment was
made because of this patient’s history of infrarenal
and thoracoabdominal aortic replacement. The final
part of his native descending aorta was going to be
excluded by stenting. For these reasons the decision
was made to continue CSF drainage for 48 hours post-
operatively and an extra CSF sample was taken after
48 hours.Eur J Vasc Endovasc Surg Vol 34, August 2007The CSF concentrations of S100b protein were ana-
lyzed with a commercially available enzyme-linked
immunosorbent assay kit (Sangtec_100 ELISA kit,
Sangtec Molecular Diagnostics AB, Bromma, Sweden).
All samples were analyzed in duplicate, with a variation
of less than 10%. A measurement takes approximately
two hours.
Results
No significant increase in S100b protein during the
procedures could be demonstrated in CSF and no cen-
tral or peripheral neurological deficits were detected
postoperatively.
However in the one patient, who was considered to
have the highest risk for developing postoperative
paraplegia or paraparesis, we found a more than three
fold increase in the S100b concentration in CSF. This
relative increase normalized during the second post-
operative day (Fig. 1). Despite this temporary relative
increase the absolute value of S100b protein stayed
within the normal range. This patient showed no clin-
ical signs of neurological damage postoperatively.
Discussion
The results of this study show that there is no signif-
icant release of S100b protein in CSF during stenting
of the thoracic aorta in this small subgroup of patients
at high risk for spinal cord ischemia. This correlated
with the absence of postoperative neurological deficits
and suggests that there may have been no significant
damage to the central nervous system.
The normal range of S100b protein in CSF however
may differ per person and it remains unknown
whether one should focus on absolute or relative in-
creases in S100b protein when monitoring damage
to the central nervous system.
Postoperative neurologic deficits are caused by in-
terruption of sufficient duration of spinal cord blood
supply. A CT angiography was performed in all pa-
tients in order to accurately size the stents needed,
however, in our hospital it was not accurate enough
to reliably identify all intercostal arteries supplying
the spinal cord. Preoperative spinal cord angiography
was not performed. Angiographic localization itself
can cause serious complications such as emboli.
Furthermore paralysis after elective open repair still
occurs among those with preoperative detailed spinal
cord blood supply.
Important may be the fact that measuring the S100b
protein concentration in CSF in this small group of
patients meant that we also took a protective measure.
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nal fluid pressure at 10 mm of Hg or less to help pre-
vent damage to the spinal cord. Perfusion pressure of
the spinal cord is equal to mean arterial blood pres-
sure less venous pressure or CSF pressure, whichever
is higher. Therefore keeping the CSF pressure low
may improve perfusion of the spinal cord. For these
reasons the release of S100b might have been altered
by our treatment. It was considered unethical though
not to keep the spinal fluid pressure at safe levels.
The value of 10 mm Hg was chosen because it has
been proven that keeping the CSF pressure at 10 mm
Hg or less helps to protect against ischemic damage to
the spinal cord during and after surgical replacement
of the thoracoabdominal aorta.1,7,8,15,16 However,
Fig. 1. Vertical axis: Boxplots show the median, interquartile
range and extremes of the concentration (mg/L) of S100b
protein in CSF. The asterisk shows the samples of the
extreme high risk patient, while the boxplots represent the
samples of the other seven patients.
Horizontal axis: the different samples taken:
Sample 1: After induction of anesthesia
Sample 2: During placement of the stent
Sample 3: One hour after stent placement
Sample 4: Two hours after stent placement
Sample 5: Three hours after stent placement
Sample 6: Four hours after stent placement
Sample 7: Five hours after stent placement
Sample 8: Six hours after stent placement
Sample 9: Twenty hours after stent placement
Sample 10: Forty-eight hours after stent placementvalues below 10 mm Hg may be associated with
a rise in complications like intracerebellar hema-
toma17 or subdural hematoma.18,19
In addition to these complications persistent CSF
leakage,20 hematoma formation around the cauda
equina18 and bacterial meningitis21 may also occur.
Whether there is an indication for CSF drainage in
a subgroup of patients at high risk to develop neuro-
logical deficits after endovascular repair has never
been defined.
Following endovascular thoracic aortic aneurysm
repair, there are several case reports that show rever-
sal of postoperative paraplegia after institution of
cerebrospinal fluid drainage.22e24 Patients after endo-
vascular repair can be neurologically examined
directly postoperative. Immediate postoperative CSF
drainage may possibly be almost as effective as pre-
operative institution of CSF drainage, because of the
short duration of preventable spinal cord ischemia.
The complications of CSF drainage can be life
threatening, which is why its management should
not be taken lightly. Considering the fact that lumbar
CSF drainage is not without risks25 the indications for
its use during thoracic endovascular stent grafting re-
main to be studied, since even in this small subgroup
of patients at high risk to develop postoperative para-
plegia or paraparesis there was no rise in S100b
protein in the CSF.
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